926345

NanoFabTx™-DC-Chol Lipid Mix

for synthesis of cationic (DC-cholesterol) liposomes

Manufacturer: Sigma Aldrich

Select a Size

Pack Size SKU Availability Price
50 MG 926345-50-MG In Stock ₹ 29,140.00
100 MG 926345-100-MG In Stock ₹ 43,750.00

926345 - 50 MG

₹ 29,140.00

In Stock

Quantity

1

Base Price: ₹ 29,140.00

GST (18%): ₹ 5,245.20

Total Price: ₹ 34,385.20

Quality Level

100

storage temp.

−20°C

Related Products

Img

Sigma Aldrich

926027

for synthesis of cationic (DOTAP) l...

Img

Sigma Aldrich

930113

for synthesis of carboxyl functiona...

Img

Sigma Aldrich

934194

--

Img

Sigma Aldrich

934208

--

Img

Sigma Aldrich

934216

--

Img

Sigma Aldrich

937231

--

Img

Sigma Aldrich

922420

for synthesis of PEGylated liposome...

Img

Sigma Aldrich

937266

--

Description

  • General description: NanoFabTx™-DC-Chol Lipid Mix; for synthesis of cationic (DC-cholesterol) liposomes is a ready-to-use nanoformulation blend for the synthesis of liposomes for drug delivery. The NanoFabTx™-DC-Chol Lipid Mix includes optimized protocols with step-by-step instructions for synthesizing cationic DC-cholesterol liposomes for drug delivery applications. The modification of the liposomes with the cationic lipid, DC-cholesterol, have numerous advantages including high gene transfection efficiency. Liposome-based formulations are widely used for drug delivery applications and enable improved therapeutic efficacy of a range of drug types including small molecules, nucleic acids, proteins, and peptides.
  • Application: About NanoFabTx™NanoFabTx™ lipid mixes and formulation kits enable users to encapsulate a wide variety of therapuetic drug molecules for targeted or extended drug delivery without the need for lengthy trial-and-error optimization. NanoFabTx™ reagent kits provide an easy-to-use toolkit for encapsulating a variety of therapeutics in nanoparticles, microparticles, or liposomes. Drug encapsulated particles synthesized with the NanoFabTx™ kits are suitable for biomedical research applications such as oncology, immuno-oncology, gene delivery, and vaccine delivery.
  • Features and Benefits: A ready-to-use nanoformulation blend for the synthesis of cationic DC-cholesterol liposomes Step-by-step protocols (extrusion or microfluidic) developed and tested by our formulation scientistsFlexible synthesis tools to create uniform and reproducible liposomesOptimized to make liposomes around 100 nm with low polydispersityDC-Cholesterol allows for high transfection efficiency and targeted drug deliveryComprehensive protocols for liposome synthesis are included:A lipid film hydration and extrusion protocol.A microfluidics protocol using commercial platforms or syringe pumps. The microfluidics protocol included with this product uses the NanoFabTx™ device kit (911593). These kits are ready-to-use and include the microfluidic chip, fittings, and tubing required for microfluidics-based synthesis (compatible microfluidics system or syringe pump required).
  • Legal Information: NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

SAFETY INFORMATION

WGK

WGK 3

Compare Similar Items

Show Difference

Img

Sigma Aldrich

926345

for synthesis of cationic (DC-chole...


Quality Level:
100

storage temp.:
−20°C

Img

Fischer Scientific

9264005

An irradiated, fine point permanent...


Quality Level:
__

storage temp.:
__

Img

Fischer Scientific

9264016

Carry out multiple applications wit...


Quality Level:
__

storage temp.:
__

Img

Supelco

92648

analytical standard...


Quality Level:
100

storage temp.:
__